Advertisement

Topics

Today’s Jaguar Health Conference Call Moved to 5:45 p.m. Eastern Time

15:27 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
First Post-Merger Earnings Call for Jaguar and its Wholly-Owned Subsidiary, Napo Pharmaceuticals, Regarding Sales of Napo’s FDA-Approved Human Drug, Mytesi, an Antidiarrheal Indicated for the Symptomatic Relief of Noninfectiou...

Other Sources for this Article

Jaguar Health, Inc.
Peter Hodge
phodge@jaguar.health

NEXT ARTICLE

More From BioPortfolio on "Today’s Jaguar Health Conference Call Moved to 5:45 p.m. Eastern Time"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...